Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jul 26.
Published in final edited form as: Int J Cancer. 2016 Feb 3;138(11):2602–2615. doi: 10.1002/ijc.29994

WCRF/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors

Sarah J O Nomura 1, Maki Inoue-Choi 2, DeAnn Lazovich 3,4, Kim Robien 5
PMCID: PMC5528152  NIHMSID: NIHMS884474  PMID: 26756307

Abstract

Taller height, family history of breast cancer, greater number of years of potential fertility and nulliparity are established non-modifiable risk factors for postmenopausal breast cancer. Greater adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) diet, physical activity and body weight recommendations has previously been shown to be associated with lower breast cancer risk. However, no prior studies have evaluated whether women with non-modifiable risk factors receive similar benefits from recommendation adherence compared to women without these risk factors. In the Iowa Women’s Health Study prospective cohort, we investigated whether associations of WCRF/AICR recommendation adherence differed by the presence/absence of non-modifiable breast cancer risk factors. Baseline (1986) questionnaire data from 36,626 postmenopausal women were used to create adherence scores for the WCRF/AICR recommendations (maximum score=8.0). Overall and single recommendation adherence in relation to breast cancer risk (n=3,189 cases) across levels of non-modifiable risk factors were evaluated using proportional hazards regression. Mean adherence score was 5.0 points (range: 0.5–8.0). Higher adherence scores (score ≥6.0 vs. ≤3.5, HR=0.76, 95% CI=0.67–0.87), and adherence to the individual recommendations for body weight and alcohol intake were associated with a lower breast cancer incidence. While not statistically significant among women with more non-modifiable risk factors (score ≥6.0 vs. ≤3.5, HR=0.76, 95% CI=0.36–1.63), hazard ratios were comparable to women with the no non-modifiable risk factors (score ≥6.0 vs. ≤3.5, HR=0.74, 95% CI=0.49–0.93) (p-interaction=0.57). WCRF/AICR recommendation adherence is associated with lower breast cancer risk, regardless of non-modifiable risk factor status.

Keywords: Breast Cancer, Diet, Body Weight, Physical Activity, Cancer Prevention

INTRODUCTION

An estimated one in eight women will develop breast cancer in her lifetime,1 and two in three invasive breast cancer cases occur among women 55 years and older.2 While several modifiable risk factors for breast cancer have been identified (including oral contraceptive use, hormone replacement use, alcohol consumption, physical activity and being overweight or obese2), several non-modifiable risk factors have also been established. Taller height, family history of breast cancer, younger age at menarche and older age at menopause have all been associated with increased risk of breast cancer.25 Nulliparity has also been shown to be associated with breast cancer risk, and may also be considered a non-modifiable risk factor because it is unlikely women will only choose to have children to prevent cancer.6, 7 Women with non-modifiable breast cancer risk factors may be especially motivated to make diet and physical activity changes to reduce their breast cancer risk. While few non-modifiable risk factors and lifestyle habits have been previously evaluated, current research suggests women at higher risk of breast cancer, due to a family history of breast cancer, are not more likely to adhere to diet, physical activity and body weight recommendations.33, 34 Whether these women derive equal, or potentially greater, benefit from healthy behaviors compared to women without these non-modifiable breast cancer risk factors is unclear.

Studies evaluating evidence-based guidelines that have been developed specifically to address cancer prevention, such as the World Cancer Research Fund and American Institute for Cancer Research (WCRF/AICR) guidelines,813 the European Code Against Cancer,14 and the American Cancer Society recommendations,10, 1517 have generally observed that greater adherence to recommendations is associated with lower cancer incidence and/or cancer mortality.8, 9, 11, 12, 14, 15 Higher adherence was also associated with a lower incidence of breast cancer in previous studies.911, 13, 16, 17 Fewer studies have evaluated the benefits of adherence to the individual recommendations.911, 13, 16 Results from these studies have been generally inconsistent, but adherence to the alcohol intake recommendation has been consistently associated with reduced breast cancer incidence. The WCRF/AICR Breast Cancer Continuous Update Project (CUP) Report indicates that adherence to alcohol, body composition and physical activity recommendations are likely to confer the greatest benefit in reducing breast cancer risk.18

In 2007, the WCRF/AICR released diet, physical activity and weight management recommendations for cancer prevention (Table 1),19 which have been most often evaluated in previous studies. No previous studies have assessed whether benefits of adherence differ among population sub-groups, such as women who may be at an increased risk for breast cancer due to non-modifiable risk factors. In this analysis, we evaluated whether the association between adherence to the 2007 WCRF/AICR recommendations and postmenopausal breast cancer incidence in the Iowa Women’s Health Study (IWHS) differs between women with and without non-modifiable risk factors, including taller height, total years of potential fertility, parity, family history of breast cancer, and a combined risk score that encompasses all these non-modifiable risk factors.

Table 1.

WCRF/AICR Guidelines and Adherence Scores

WCRF/AICR
Recommendation
IWHS Baseline
Data
Categories Score Cohort
N (%)
Cases
N (%)

Be as lean as possible without becoming underweight. BMI (kg/m2) 18.5 – < 25 1 14,108 (38.5) 1,082 (33.9)
25 – < 30 0.5 13,545 (37.0) 1,262 (39.6)
≥ 30 or < 18.5 0 8,973 (24.5) 845 (26.5)

Be physically active, for at least 30 minutes every day. Physical activity level1 High 1 9,015 (25.1) 739 (23.6)
Moderate 0.5 9,907 (27.6) 900 (28.7)
Low 0 16,994 (47.3) 1,498 (47.8)

Limit energy-dense food intake. + Avoid sugary drinks. Not included2 --- --- --- ---

High sugar beverage intake (g/d) 0 1 16,705 (45.6) 1,434 (8.58)
< 250 0.5 17,077 (46.6) 1,524 (47.8)
≥ 250 0 2,844 (7.8) 231 (7.24)

Eat more vegetables, fruits, whole grains, and legumes such as beans. Total fruit and vegetable intake (servings/d) 5 servings = 400 g 3 servings = 200 g ≥ 5 1 23,009 (62.8) 2,014 (63.2)
3 – < 5 0.5 10,125 (27.7) 889 (27.9)
< 3 0 3,492 (9.5) 286 (8.97)

Dietary fiber intake (g/d) ≥ 25 1 7,791 (21.3) 678 (21.3)
12.5 – < 25 0.5 22,634 (61.8) 1,982 (62.1)
< 12.5 0 6,201 (16.9) 529 (16.6)

Limit red meat intake and avoid processed meats. Total red and processed meat (RP) intake (g/wk) and processed meat (P) intake (g/wk) < 500 RP and < 3 P 1 6,509 (17.8) 531 (16.7)
< 500 RP and 3 – < 50 P 0.5 22,933 (62.6) 2,042 (64.0)
< 500 RP or ≥ 50 P 0 7,184 (19.6) 616 (19.3)

Limit alcohol drinks to 2 for men and 1 for women a day, if consumed at all. Alcohol intake (g/d) (1 standard alcohol serving = 10 g) ≤ 10 1 32,320 (88.2) 2,773 (87.0)
> 10 – 20 0.5 2,700 (7.4) 258 (8.09)
> 20 0 1,606 (4.4) 158 (4.95)

Limit intake of salty foods and foods processed with salt. Sodium intake (mg/d) ≤ 1500 1 7,528 (20.6) 666 (20.9)
>1500 – 2400 0.5 17,023 (46.5) 1,433 (44.9)
> 2400 0 12,075 (32.9) 1,090 (34.2)

Don’t use supplements to protect against cancer. Not included3 --- --- --- ---

Overall Adherence Score Sum of Scores (Max score = 8) 6.0 – 8.0 --- 6,597 (18.4) 501 (16.0)
5.0 – 5.5 11,626 (32.4) 1,050 (33.5)
4.0 – 4.5 11,818 (32.9) 1,040 (33.1)
0 – 3.5 5,875 (16.4) 546 (17.4)

Diet Adherence Score Sum of Dietary Scores (Max score = 6) 4.5 – 6.0 --- 10,719 (29.3) 917 (28.8)
3.0 – 4.0 22,768 (62.2) 2,025 (63.5)
0 – 2.5 3,139 (8.57) 247 (7.75)
1

“High” if reported ≥2 times/week vigorous (e.g., jogging, racket sports, swimming, aerobics, strenuous sports) or ≥5 times/week moderate activities (e.g., bowling, golf, light sports, or physical exercise, gardening, taking long walks), “Moderate” if they reported 2–4 times/week moderate or once/week vigorous and moderate activities, or otherwise “Low”

2

Data on caloric intake by food gram was not available.

3

Insufficient data on supplement usage were collected.

MATERIALS AND METHODS

Study Population

The IWHS is a prospective cohort study designed to investigate diet and lifestyle factors with risk of cancer and other chronic diseases among postmenopausal women ages 55 – 69 years at enrollment in 1986.20 Women were identified using the Iowa Department of Transportation drivers’ license lists; 41,836 women (42% response rate) provided information on demographic, anthropometric, medical, reproductive, and family history, lifestyle factors and dietary intake data via a self-administered questionnaire. The final analytic cohort included 36,626 postmenopausal women, after excluding women who left >30 items blank on the dietary intake section of the questionnaire, had implausible estimated caloric intake (<600 or >5,000 kcal/day) (n = 2,712), were not postmenopausal at baseline (n = 569), or reported a previous mastectomy (n = 1,884) or cancer diagnosis (except for non-melanoma skin cancer) at baseline (n = 3,830). Incident cancers in the IWHS are identified through annual linkage with the State Health Registry of Iowa, a member of the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program. Since annual migration from Iowa among cohort members is <1%, identification of incident cancers is nearly complete.21 The IWHS has been approved by the Institutional Review Boards at the University of Minnesota and the University of Iowa.

Data Collection

The Harvard food frequency questionnaire (FFQ) was used to assess usual intake frequency of 127 food items at baseline.22, 23 This questionnaire has been validated in the IWHS population.24 Grams of intake of food groups (total fruit and vegetable intake, red and processed meat intake) and individual nutrients (fiber, sodium) were computed based on reported serving numbers and portion sizes for each item. Grams of sugar sweetened beverage intake included (i) Coke, Pepsi, or other cola with sugar; (ii) caffeine-free Coke, Pepsi or other cola with sugar; (ii) other carbonated beverage with sugar (e.g. 7-up); (iv) Hawaiian Punch, lemonade, or other non-carbonated fruit drink. For physical activity, women were categorized as “high” (≥2 times/week vigorous or ≥5 times/week moderate activities), “moderate” (2–4 times/week moderate or once/week both vigorous and moderate activities) or “low” (all other activity levels).25 Women also reported their age at menarche, age at menopause, number of live births, family history of cancer, height and weight. Body mass index (BMI) was calculated as kilograms/meter.2

WCRF/AICR Guideline Adherence Score

The guidelines and scoring system are outlined in Table 1. Adherence scores for the WCRF/AICR cancer prevention guidelines were calculated according to baseline measures of BMI (normal BMI: 18.5 – <25; overweight BMI: 25 – <30; obese or underweight BMI: ≥30 or <18.5 kg/m2), physical activity (high activity levels; moderate activity levels; low activity levels), and intake of fruits and vegetables (≥400, 200 – <400, <200 grams/day), fiber (≥25; 12.5 – <25; <12.5 grams/day), alcohol (≤10; >10 – 20; >20 grams/day) (standard single serving of alcohol = 10 grams), red and processed meat (<500 grams/week total red and processed and < 3 grams/week processed; <500 grams/week total red and processed and 3 – <50 grams/week processed; ≥500 grams/week total red and processed or ≥50 grams/day processed), sugar sweetened beverages (0 grams/day; <250 grams/day, ≥250 grams/day) and sodium (<1500 mg/day; 1500 – 2400 mg/day, >2400 mg/day). When specific cut-points were specified in the WCRF/AICR recommendations, these were used in score creation. Given the age of this cohort of postmenopausal women, we chose a lower sodium intake cut-point (<2400 mg/d) for our analysis, based on the United States Dietary Guidelines recommendation for people ≥ 51 years of age.26 These cut-points have been used in several previous published IWHS analyses.27, 28 The recommendation to limit energy dense foods was not included due to a lack of data on caloric intake by food gram. The dietary supplement recommendation was excluded due to a lack of information on whether supplement usage was medically indicated or elective. For each individual recommendation, 1 point was assigned for complete adherence, 0.5 points for partial adherence and 0 points for non-adherence. Scores for each of the individual recommendations were then summed to a total WCRF/AICR recommendation adherence score (maximum score: 8 points). Three levels were used instead of met/did not meet to be better able to assess differences between those who were most adherent compared to those who were least adherent. Additionally, a diet adherence score was created by summing scores for the six diet recommendations (maximum score: 6 points).

Statistical Analysis

Person-years of follow-up time for each participant were computed from the date of the return of baseline questionnaire to 1) date of first breast cancer diagnosis, 2) date of emigration for Iowa, 3) date of death, or 4) December 31, 2010, whichever came first.

Associations between risk factors, demographic and lifestyle characteristics and the WCRF/AICR adherence scores overall and by individual recommendation were evaluated using Pearson correlations, chi-square tests and ANOVA. The WCRF/AICR adherence score was evaluated as a continuous variable and as categorical (≤3.5 points, 4.0 – 4.5 points, 5.0 – 5.5 points, ≥6.0 points). Four categorical levels were chosen to clearly differentiate between those with high vs. low adherence centered on a median score of 4.5 points and assess the benefits of adhering to at least half the recommendations compared to adherence to less than or more than half the recommendations. Cox proportional hazards regression was used to calculate unadjusted and multivariable-adjusted hazard ratios (HR) and 95% confidence intervals (CI) for associations between WCRF/AICR adherence scores and breast cancer incidence. Associations between WCRF/AICR adherence scores and breast cancer risk were evaluated in the total population and in each stratum of the following non-modifiable risk factors: height (tertiles), family history of breast cancer (none, history of breast cancer in grandmother only, history of breast cancer in mother/sister), parity (none, 1–2, ≥ 3 children) and total years of fertility (age at menopause – age at menarche) (tertiles). Since the effects of age at menopause and age at menarche are hypothesized to be due to the number of lifetime menstrual cycles (in combination with parity), these variables were combined into a total number of years of potential fertility. The choice of non-modifiable risk factors were chosen a priori based on factors previously shown to be associated with breast cancer risk.27

To evaluate whether there were differences among women whom had a larger number of non-modifiable risk factors compared to women who had one or none of the non-modifiable risk factors we created a combined number of risk factors variable. The number of non-modifiable risk factors for which a participant was in the highest risk category (defined based on previously published research27) for the individual factors were summed. The highest risk category for each individual non-modifiable risk factor as follows: parity –nulliparous; height (tertiles) - ≥ 166 cm; family history –first-degree relative; total years of potential fertility (duration from age at menarche to age at menopause tertile) - ≥ 39 years (highest). Based on their number of non-modifiable risk factors women were assigned to one of four categories: No non-modifiable risk factors, one risk factor, two risk factors, at least 3 risk factors.

Associations between the non-modifiable risk factors and breast cancer incidence were evaluated using Cox proportional hazards regression. Analyses stratified by non-modifiable risk factors and combined number of risk factors were performed in the regression models to evaluate the benefits of adherence across risk factor levels. A test for interaction was performed in the Cox regression models by adding an interaction term with WCRF/AICR score (continuous and categorical) and the individual (3 categories) or combined (four categories) non-modifiable risk factors. Covariates were included in final models if they were known risk factors for breast cancer or were significantly associated with the WCRF/AICR adherence score. All adjusted models included age (continuous), smoking status (current, former, never), education (< high school, high school, some college/vocational, college), and hormone replacement therapy usage (yes/no). Additional covariates included family history of breast cancer (none, grandmother, mother/sister, multiple relatives), menarche age (continuous), menopause age (continuous), and parity (yes/no) except in models where associations were evaluated according to that non-modifiable risk factor. Similarly, BMI/alcohol/physical activity variables were included in models where BMI/alcohol/physical activity score were not the exposure of interest.

We also evaluated associations between adherence to diet recommendations only (continuous and categorical: ≤2.5, 3.0 – 4.0, ≥ 4.5) and individual WCRF/AICR recommendations (continuous and categorical: 0 points, 0.5 points, 1 point) and breast cancer incidence using Cox proportional hazards regression. Diet category cut-points were chosen to reflect low adherence, adherence to at least half, and high adherence. In addition to the covariates listed above, the analyses of associations between adherence to each dietary recommendation and breast cancer risk were adjusted for BMI and/or alcohol, depending on the recommendation being evaluated.

Multivariate adjusted absolute risk difference was calculated for the overall score and individual recommendations in the overall cohort using the approach outlined by Spiegelman and Hertzmark.29 Analyses were performed with SAS (version 9.2; SAS Institute, Inc.). Statistical significance was defined as p < 0.05 (two-sided).

RESULTS

A total of 3,189 women were diagnosed with incident breast cancer from baseline through December 31, 2010. The mean WCRF/AICR adherence score was 5.0 (range 0.5 – 8.0), and 32.9% of participants had a score of 4.0 or 4.5 (Table 1). Participants were least likely to meet the physical activity recommendation (47.3%) and most likely to follow the alcohol intake recommendation (88.2%). Except for adherence to fiber intake and fruit and vegetables recommendations (r=0.60, p<0.001) and adherence to sodium intake in relation to adherence to red and processed meat intake (r=0.29, p<0.001) and fruit and vegetable intake (r=−0.35, p<0.001), adherence to any one individual recommendation was generally not strongly correlated (positively or inversely) with adherence to any other recommendation (range: r=−0.11 to 0.17). Older age, higher levels of education, and no history of smoking were associated with higher adherence scores (p < 0.001) (Table 2). Age at menopause, parity, and height were also significantly associated with the WCRF/AICR adherence score, but no clear pattern to the HRs was observed across adherence score levels. In unadjusted models, all factors included in this risk score (parity, taller height, family history for breast cancer and years of fertility) were significantly associated with breast cancer incidence in this study population (Supplementary Table 1). In adjusted models, parity was no longer significantly associated with breast cancer risk. Since study results did not differ, risk factors were chosen a priori, and parity was previously shown to be associated with number of live births in the IWHS we included parity in presented study results.7 Similarly, in the Cox regression analysis, increasing numbers of non-modifiable risk factors was positively associated with breast cancer incidence and associations were strongest among women at least three non-modifiable risk factors.

Table 2.

Population Characteristics According to WCRF/AICR Score Group

Breast Cancer Status WCRF/AICR Score Group


IWHS
Cohort
Breast
Cancer
Cases
P1 Group 1
(0 − 3.5)
Group 2
(4.0 − 4.5)
Group 3
(5.0 − 5.5)
Group 4
(6.0 − 8.0)
P2

Age (mean ± SD) 61.7 ± 4.2 61.6 ± 4.1 0.063 61.1 ± 4.1 61.6 ± 4.2 61.9 ± 4.2 62.0 ± 4.2 <0.0013

Calories (mean ± SD) 1,785 ± 614 1,787 ± 615 0.263 1,882 ± 648 1,835 ± 648 1,769 ± 593 1,649 ± 518 <0.0013

Level of Education (%) <0.0014 <0.0014
  <High school graduate 7,062 (19.3) 519 (16.3) 1,463 (25.0) 2,409 (20.8) 1,998 (13.9) 912 (13.9)
  High school graduate 15,262 (41.8) 1,325 (41.6) 2,681 (45.8) 5,046 (43.5) 4,816 (40.9) 2,464 (37.4)
  Some college/vocational 9,668 (26.5) 905 (28.4) 1,279 (21.8) 3,007 (25.9) 3,307 (28.1) 1,950 (29.6)
  College graduate 4,538 (12.4) 437 (13.7) 436 (7.44) 1,133 (9.77) 1,665 (14.1) 1,259 (19.1)

Smoking Status (%) 0.044 <0.0014
  Never 23,772 (65.9) 2,208 (66.9) 3,282 (56.7) 7,501 (65.4) 7,998 (68.7) 4,501 (69.2)
  Former 6,941 (19.24) 623 (19.8) 1,120 (19.3) 2,098 (18.3) 2,203 (18.9) 1,426 (21.9)
  Current 5,357 (14.9) 420 (13.3) 1,388 (24.0) 1,878 (16.4) 1,443 (12.4) 579 (8.9)

Age at Menarche (%) 0.394 0.194
  ≤ 12 years 15,425 (42.6) 1,382 (43.7) 2,508 (43.2) 4,939 (43.0) 4,937 (42.2) 2,768 (42.3)
  13 years 10,738 (29.7) 931 (29.4) 1,728 (29.8) 3,299 (28.7) 3,501 (29.9) 1,984 (30.3)
  ≥ 14 years 10,051 (27.8) 852 (26.9) 1,568 (27.0) 3,244 (28.3) 3,267 (27.9) 1,788 (27.3)

Age at Menopause (%) <0.0014 <0.0014
  ≤ 46 years 12,196 (34.5) 1,001 (32.3) 2,046 (36.1) 3,950 (35.1) 3,874 (33.9) 2,087 (32.8)
  47–50 years 10,433 (29.5) 860 (27.8) 1,684 (29.7) 3,274 (29.1) 3,376 (29.5) 1,904 (29.9)
  ≥ 51 years 12,763 (36.1) 1,234 (39.9) 1,937 (34.2) 4,024 (35.8) 4,195 (36.7) 2,378 (37.2)

Potential Fertility Years 0.0024 0.0014
  ≤ 33 years 12,009 (34.2) 978 (31.8) 2,001 (35.5) 3,912 (35.0) 3,808 (33.5) 2,055 (32.4)
  34–38 years 12,177 (27.6) 1,062 (27.9) 1,929 (34.2) 3,821 (34.2) 4,009 (35.3) 2,207 (34.8)
  ≥ 39 years 23,009 (62.8) 2,014 (63.2) 1,703 (30.2) 2,435 (30.8) 3,552 (31.2) 2,079 (32.8)

Parity (%) 0.644 <0.0014
  None 3,272 (11.1) 292 (11.0) 481 (10.7) 1,002 (10.9) 1,088 (11.3) 642 (11.5)
  1–2 children 11,702 (39.8) 1,074 (40.6) 1,728 (38.4) 3,582 (39.0) 3,841 (39.9) 2,323 (41.7)
  3 or more 14,437 (49.1) 1,277 (48.3) 2,289 (50.9) 4,600 (50.1) 4,690 (48.8) 2,600 (46.7)

Height (%) <0.0014 <0.0014
  ≤160 cm 9,873 (27.0) 742 (23.3) 1,681 (28.6) 3,140 (26.9) 3,177 (26.9) 1,677 (25.4)
  >160–<165 cm 16,113 (44.0) 1,400 (43.9) 2,550 (43.4) 5,184 (43.9) 5,184 (43.9) 2,887 (43.8)
  ≥ 165 cm 10,640 (29.0) 1,047 (32.8) 1,644 (28.0) 3,457 (29.3) 3,457 (29.3) 2,033 (30.8)

Family History5 <0.0014 0.714
  None 26,766 (76.6) 2,137 (70.0) 4,293 (76.7) 8,537 (76.7) 8,657 (76.6) 4,826 (76.4)
  Second degree 3,946 (11.3) 392 (12.8) 622 (11.1) 1,242 (11.2) 1,316 (11.7) 710 (11.2)
  First degree 4,232 (12.1) 523 (17.1) 686 (12.3) 1,359 (12.2) 1,322 (11.7) 783 (12.4)

Combined Factors (%) <0.001 <0.0014
  None 11,861 (38.8) 968 (33.0) 2,152 (40.1) 4,175 (39.1) 4,138 (38.1) 2,149 (35.5)
  1 risk factor 12,979 (42.5) 1,241 (42.3) 2,230 (41.6) 4,505 (42.2) 4,615 (42.5) 2,648 (43.7)
  2 risk factors 5,059 (16.6) 627 (21.3) 877 (16.3) 1,776 (16.6) 1,841 (17.0) 1,103 (18.2)
  3+ risk factors 651 (2.1) 101 (3.4) 107 (2.0) 218 (2.1) 255 (2.4) 158 (2.6)
1

Compares cases to non-cases in cohort

2

Compares WCRF/AICR score categories

3

p-value from ANOVA test

4

p-value from x2 test for categorical variables

5

Breast cancer

A higher adherence score on the continuous scale was associated with lower breast cancer risk (HR=0.94, 95% CI: 0.90 – 0.97 per 0.5 point increase in adherence score) (data not shown). Using a categorical scale of the adherence score, women who adhered to six or more out of eight recommendations had the lowest risk of breast cancer (adjusted HR=0.76, 95% CI: 0.67–0.87) compared with women who adhered to less than half of the eight recommendations (Table 3). Absolute risk difference (RD) for higher adherence compared to lower adherence was small, but statistically significant for the overall score (>6 vs. <3.5 recommendations RD=−0.022 (−0.033, −0.012, p<0.001) (Supplementary Table 2). Regardless of height, adherence to a larger number of recommendations was associated with lower breast cancer incidence, although the association was weaker among the women in the tallest tertile (p-interaction = 0.50). The pattern was similar for years of fertility, where the hazard ratios and confidence intervals were similar for the lowest (adjusted HR for the highest vs. lowest score categories: 0.72, 95% CI: 0.57–0.91) and middle tertiles (adjusted HR for the highest vs. lowest score categories: 0.74, 95% CI: 0.59–0.92), but slightly weaker among women with the most years of fertility (adjusted HR for the highest vs. lowest score categories: 0.81, 95% CI: 0.65–1.01, p-interaction = 0.66). Benefits of adherence were similar among women with no children and women with one to two children. While greater adherence was still protective in women who had three or more children, the association was weaker compared with the other parity categories (p-interaction = 0.09). Despite a non-significant interaction (p-interaction = 0.60), associations between the WCRF/AICR adherence score and breast cancer risk were stronger among women with no family history of breast cancer (adjusted HR for the highest vs. lowest score categories=0.70, 95% CI: 0.60–0.82), while higher adherence was not significantly associated with breast cancer incidence among women with first or second-degree relatives with a history of breast cancer. The test for interaction between WCRF/AICR adherence score and combined number of risk factors was not significant (p=0.57). Among women with the fewest non-modifiable risk factors higher adherence was statistically significantly association with lower breast cancer incidence (adjusted HR for the highest vs. lowest score categories: 0.74, 95% CI: 0.59–0.93). While not statistically significant, higher adherence was also inversely associated among women with the greatest number of non-modifiable risk factors (adjusted HR for the highest vs. lowest score categories: 0.76, 95% CI 0.36–1.63).

Table 3.

Hazard ratios (HR) and 95% confidence intervals (CI) for breast cancer incidence in relation to WCRF/AICR adherence score

Reference WCRF/AICR Adherence Scores
Unadjusted HR
WCRF/AICR Adherence Scores
Multivariable Adjusted HR
N Cases/N
Total
Group 1
(0 − 3.5)
Group 2
(4.0 − 4.5)
Group 3
(5.0 − 5.5)
Group 4
(6.0 − 8.0)
Ptrend1 Pint Group 2
(4.0 − 4.5)
Group 3
(5.0 − 5.5)
Group 4
(6.0 − 8.0)
Ptrend1 Pint

Overall2 3,189/36,626 1.0 (ref) 1.01 (0.91–1.12) 1.04 (0.93–1.15) 0.90 (0.80–1.02) 0.07 --- 0.92 (0.83–1.03) 0.90 (0.81–1.00) 0.76 (0.67–0.87) <0.001 ---

Height2,3 0.78 0.50
  ≤160 cm 742/9,873 1.0 (ref) 1.06 (0.86–1.32) 1.10 (0.89–1.36) 0.86 (0.67–1.12) 0.20 0.98 (0.78–1.22) 0.98 (0.78–1.23) 0.73 (0.55–0.96) 0.08
  >160–<165 cm 1,400/16,113 1.0 (ref) 0.96 (0.83–1.13) 0.95 (0.81–1.11) 0.88 (0.74–1.06) 0.59 0.85 (0.72–1.00) 0.79 (0.67–0.93) 0.73 (0.60–0.89) 0.008
  ≥ 165 cm 1,047/10,640 1.0 (ref) 1.02 (0.85–1.23) 1.10 (0.91–1.32) 0.92 (0.75–1.14) 0.31 0.99 (0.81–1.20) 1.02 (0.83–1.24) 0.84 (0.67–1.05) 0.24

Fertility Years3,4,5 0.70 0.66
  ≤ 33 978/12,009 1.0 (ref) 1.03 (0.86–1.23) 1.04 (0.86–1.24) 0.85 (0.68–1.06) 0.22 0.93 (0.77–1.13) 0.93 (0.77–1.13) 0.72 (0.57–0.91) 0.03
  34–38 years 1,062/12,177 1.0 (ref) 1.02 (0.86–1.22) 0.96 (0.80–1.15) 0.95 (0.77–1.17) 0.82 0.90 (0.75–1.08) 0.78 (0.65–0.95) 0.74 (0.59–0.92) 0.02
  ≥ 39 years 1,040/10,969 1.0 (ref) 0.94 (0.78–1.13) 1.04 (0.87–1.25) 0.88 (0.71–1.09) 0.28 0.92 (0.76–1.12) 0.98 (0.81–1.19) 0.81 (0.65–1.01) 0.18

Parity6 0.12 0.09
  None 292/3,272 1.0 (ref) 1.18 (0.84–1.67) 0.95 (0.67–1.35) 0.73 (0.48–1.10) 0.05 1.08 (0.75–1.57) 0.78 (0.53–1.14) 0.66 (0.42–1.05) 0.04
  1–2 children 1,074/11,702 1.0 (ref) 0.91 (0.76–1.09) 1.05 (0.88–1.25) 0.80 (0.65–0.99) 0.02 0.81 (0.66–0.98) 0.89 (0.74–1.08) 0.68 (0.54–0.85) 0.004
  3 or more 1,277/14,437 1.0 (ref) 1.07 (0.91–1.27) 1.04 (0.88–1.23) 0.97 (0.80–1.18) 0.66 1.02 (0.86–1.22) 0.94 (0.79–1.12) 0.83 (0.68–1.02) 0.13

Family History7,8 0.69 0.60
  None 2,137/26,766 1.0 (ref) 0.97 (0.85–1.10) 0.99 (0.88–1.13) 0.86 (0.75–1.00) 0.16 0.86 (0.76–0.98) 0.84 (0.74–0.96) 0.70 (0.60–0.82) <0.001
  Second Degree 392/3,946 1.0 (ref) 1.30 (0.95–1.78) 1.31 (0.96–1.78) 1.14 (0.79–1.63) 0.30 1.20 (0.86–1.66) 1.18 (0.85–1.64) 1.01 (0.69–1.48) 0.54
  First Degree 523/4,232 1.0 (ref) 1.07 (0.83–1.38) 1.08 (0.83–1.39) 0.96 (0.71–1.29) 0.80 0.99 (0.76–1.29) 0.99 (0.75–1.30) 0.88 (0.64–1.21) 0.83

Combined Factors9 0.40 0.57
  None 968/11,861 1.0 (ref) 1.02 (0.85–1.23) 0.96 (0.80–1.16) 0.94 (0.75–1.17) 0.41 0.92 (0.76–1.11) 0.81 (0.67–0.99) 0.74 (0.59–0.93) 0.001
  1 risk factor 1,241/12,979 1.0 (ref) 0.88 (0.75–1.04) 1.00 (0.85–1.18) 0.78 (0.64–0.95) 0.12 0.82 (0.70–0.98) 0.89 (0.75–1.05) 0.69 (0.56–0.84) 0.003
  2 risk factors 627/5,059 1.0 (ref) 1.18 (0.92–1.51) 1.12 (0.88–1.44) 1.09 (0.82–1.44) 0.57 1.14 (0.89–1.47) 1.05 (0.81–1.35) 0.99 (0.74–1.31) 0.81
  3+ risk factors 101/651 1.0 (ref) 1.19 (0.63–2.27) 1.11 (0.59–2.08) 0.75 (0.35–1.58) 0.56 1.08 (0.57–2.08) 1.13 (0.60–2.16) 0.76 (0.36–1.63) 0.84
1

Score evaluated as a continuous variable Cox regression model.

2

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, menarche age, menopause age, and parity.

3

Tertiles.

4

Age at menopause – age at menarche = years of potential fertility.

5

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, and parity.

6

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, menopause age, and menarche age.

7

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, menopause age, menarche age, and parity.

8

Breast cancer; second degree = grandmother only, First degree = history in mother/sister.

9

Unadjusted and adjusted for age, smoking, education and hormone replacement therapy.

Individual Recommendation Adherence Scores

Regardless of non-modifiable risk factors, adherence to a greater number of the six dietary recommendations was not associated with lower breast cancer risk (Table 4). In the combined number of risk factors analysis, moderate or higher adherence was non-significantly associated with elevated breast cancer incidence but should be interpreted with caution due to small numbers of low adherence women. More than 60% of women adhered to between 3 and 4 diet recommendations, while less than 9% adherence to less than 3 recommendations. In the highest risk category and lowest diet adherence category there where 43 non-cases and 3 breast cancer cases. Higher adherence to the recommendation to limit alcohol drinks was moderately associated with lower risk of breast cancer in the overall cohort (HR for the highest vs. lowest score = 0.84, 95% CI = 0.71 – 1.00, p-trend=0.01). Adherence to other dietary recommendations was not associated with breast cancer risk. Adherence to the BMI recommendation was significantly associated with lower breast cancer risk (HR for the highest vs. lowest score = 0.78, 95% CI = 0.70 – 0.85, p-trend < 0.001), while higher adherence to the physical activity recommendation was associated with a borderline, statistically non-significant, lower breast cancer risk (HR for the highest vs. lowest score = 0.93, 95% CI = 0.84 – 1.02, p-trend=0.23) (Table 5). When stratified by non-modifiable risk factors, associations were generally weaker and did not differ by the presence or absence of non-modifiable risk factors. Adherence to the BMI recommendation tended to be more strongly associated with breast cancer risk in the lower levels of the non-modifiable risk factor categories and the combined risk score, but none of the interactions was significant (p-interaction = 0.40 – 0.81). Greater adherence to the alcohol recommendation appeared to be more strongly associated with a lower breast cancer incidence among women with three or more non-modifiable risk factors, however, tests for interaction were non-significant (p-interaction = 0.61) and non-adherence to the alcohol recommendation was very low (<5%) in the study population. Adherence scores for other individual recommendations listed in Table 1 were not statistically significant in the overall or stratified analyses (data not shown). Absolute risk difference for adherence vs. non-adherence was statistically significant only for the body weight recommendation (RD=−0.022, 95% CI: −0.030, −0.014, p<0.001).

Table 4.

Hazard ratios (HR) and 95% confidence intervals (CI) for breast cancer incidence in relation to diet recommendation adherence score

Reference Diet Adherence Score
Unadjusted HR
Diet Adherence Score
Multivariable Adjusted HR
0–2.5 3.0–4.0 4.5–6.0 ptrend1 pint 3.0–4.0 4.5–6.0 ptrend1 pint

Overall2,4 1.0 (ref) 1.24 (1.24–1.41) 1.25 (1.09–1.44) 0.005 --- 1.11 (0.97–1.28) 1.06 (0.91–1.24) 0.22 ---
Height3,4 0.87 0.87
  ≤160 cm 1.0 (ref) 1.32 (1.00–1.74) 1.26 (0.94–1.69) 0.14 1.20 (0.89–1.60) 1.07 (0.78–1.47) 0.28
  >160–<165 cm 1.0 (ref) 1.27 (1.04–1.56) 1.30 (1.05–1.62) 0.05 1.16 (0.93–1.45) 1.12 (0.88–1.41) 0.37
  ≥165 cm 1.0 (ref) 1.14 (0.91–1.42) 1.18 (0.93–1.50) 0.38 1.02 (0.81–1.29) 1.01 (0.79–1.31) 0.98
Fertility Years3,5,6 0.23 0.36
  ≤33 years 1.0 (ref) 1.61 (0.77–3.34) 1.13 (0.51–2.50) 0.18 0.97 (0.77–1.22) 0.91 (0.77–1.22) 0.64
  34–38 years 1.0 (ref) 1.10 (0.88–1.37) 1.06 (0.83–1.34) 0.65 1.00 (0.79–1.26) 0.95 (0.79–1.22) 0.80
  ≥39 years 1.0 (ref) 1.15 (0.92–1.44) 1.22 (0.96–1.55) 0.25 1.51 (1.14–2.01) 1.47 (1.09–1.98) 0.02
Parity7 0.48 0.37
  None 1.0 (ref) 1.16 (0.77–1.75) 1.02 (0.66–1.59) 0.56 0.96 (0.61–1.51) 0.83 (0.51–1.36) 0.59
  1–2 children 1.0 (ref) 1.11 (0.89–1.39) 1.10 (0.86–1.39) 0.65 1.00 (0.79–1.26) 0.94 (0.73–1.21) 0.73
  3 or more 1.0 (ref) 1.41 (1.13–1.75) 1.42 (1.13–1.78) 0.007 1.31 (1.04–1.65) 1.24 (0.97–1.58) 0.06
Family History8,9 0.31 0.46
  None 1.0 (ref) 1.15 (0.98–1.34) 1.18 (0.99–1.34) 0.16 1.04 (0.88–1.23) 0.99 (0.83–1.18) 0.61
  Second Degree 1.0 (ref) 1.81 (1.17–2.81) 1.83 (1.16–2.88) 0.02 1.47 (0.94–2.28) 1.45 (0.91–2.32) 0.24
  First Degree 1.0 (ref) 1.29 (0.92–1.82) 1.20 (0.83–1.72) 0.29 1.25 (0.87–1.79) 1.14 (0.78–1.68) 0.40
Combined Factors10 0.22 0.33
  None 1.0 (ref) 1.30 (1.02–1.66) 1.21 (0.94–1.58) 0.91 1.15 (0.90–1.46) 1.00 (0.76–1.30) 0.02
  1 risk factor 1.0 (ref) 1.05 (0.86–1.29) 1.15 (0.93–1.42) 0.46 0.97 (0.79–1.19) 0.99 (0.80–1.24) 0.42
  2 risk factors 1.0 (ref) 1.48 (1.06–2.08) 1.50 (1.05–2.13) 0.09 1.42 (1.01–2.00) 1.36 (0.95–1.95) 0.45
  3+ risk factors 1.0 (ref) 2.31 (0.73–7.36) 1.71 (0.52–5.62) 0.65 2.14 (0.67–6.85) 1.59 (0.48–5.30) 0.55
1

Score evaluated as a continuous variable in Cox regression model.

2

Combined dietary recommendations (score range 0 – 6.0).

3

Tertiles.

4

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, menarche age, menopause age, parity, BMI and physical activity.

5

Age at menopause – age at menarche = years of potential fertility.

6

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, parity, BMI and physical activity.

7

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, menopause age, menarche age, BMI and physical activity.

8

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, menopause age, menarche age, parity, BMI and physical activity.

9

Breast cancer; second degree = grandmother only, First degree = history in mother/sister.

10

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, BMI and physical activity.

Table 5.

Adjusted hazard ratios (HR) and 95% confidence intervals (CI) for breast cancer incidence and adherence to alcohol, body weight, and physical activity recommendations

Reference Alcohol Recommendation Body Weight Recommendation Physical Activity Recommendation

0 0.5 1.0 ptrend1 pint 0.5 1.0 ptrend1 pint 0.5 1.0 ptrend1 pint

Overall2 1.0 0.99 (0.81–1.22) 0.84 (0.71–1.00) 0.01 --- 0.96 (0.97–1.05) 0.78 (0.70–0.85) <0.001 --- 1.00 (0.91–1.09) 0.93 (0.84–1.02) 0.23 ---
Height3,4 0.77 0.40 0.76
  ≤160 cm 1.0 1.00 (0.65–1.55) 0.82 (0.57–1.18) 0.23 0.98 (0.81–1.17) 0.76 (0.62–0.92) 0.008 0.94 (0.78–1.12) 0.86 (0.71–1.05) 0.35
  >160–<165 cm 1.0 1.02 (0.74–1.40) 0.94 (0.72–1.23) 0.73 0.97 (0.84–1.11) 0.73 (0.63–0.84) <0.001 0.99 (0.86–1.13) 0.94 (0.81–1.08) 0.64
  ≥165 cm Fertility 1.0 0.95 (0.67–1.35) 0.75 (0.56–1.00) 0.03 0.94 (0.79–1.12) 0.86 (0.72–1.02) 0.20 1.06 (0.91–1.24) 0.96 (0.82–1.13) 0.52
Years3,5 0.94 0.81 0.95
  ≤33 years 1.0 1.36 (0.95–1.94) 0.90 (0.66–1.23) <0.001 0.96 (0.82–1.14) 0.79 (0.67–0.94) 0.009 0.98 (0.84–1.15) 0.96 (0.82–1.14) 0.90
  34–38 years 1.0 0.86 (0.61–1.21) 0.76 (0.58–1.00) 0.11 0.91 (0.78–1.07) 0.71 (0.60–0.83) <0.001 1.00 (0.86–1.16) 0.89 (0.76–1.04) 0.30
  ≥39 years 1.0 0.85 (0.58–1.24) 0.92 (0.67–1.27) 0.68 0.99 (0.85–1.16) 0.84 (0.71–0.99) 0.04 0.99 (0.85–1.16) 0.92 (0.79–1.08) 0.55
Parity6 0.91 0.44 0.55
  None 1.0 1.33 (0.69–2.55) 0.91 (0.52–1.59) 0.24 0.84 (0.62–1.15) 0.67 (0.49–0.93) 0.05 0.91 (0.68–1.22) 0.78 (0.57–1.07) 0.31
  1–2 children 1.0 1.14 (0.81–1.61) 0.89 (0.67–1.19) 0.08 0.93 (0.78–1.09) 0.76 (0.64–0.90) 0.002 1.08 (0.93–1.25) 0.96 (0.82–1.13) 0.42
  3 or more 1.0 1.00 (0.72–1.39) 0.85 (0.65–1.12) 0.21 1.02 (0.88–1.18) 0.85 (0.73–0.99) 0.02 0.94 (0.82–1.08) 0.88 (0.76–1.02) 0.21
Family History7,8 0.71 0.81 0.63
  None 1.0 1.06 (0.82–1.36) 0.90 (0.73–1.11) 0.11 0.96 (0.86–1.07) 0.75 (0.67–0.84) <0.001 0.97 (0.87–1.08) 0.89 (0.80–1.00) 0.13
  Second Degree 1.0 0.77 (0.43–1.38) 0.69 (0.43–1.09) 0.26 0.92 (0.71–1.20) 0.86 (0.66–1.13) 0.55 0.98 (0.77–1.26) 1.07 (0.83–1.39) 0.82
  First Degree 1.0 0.91 (0.57–1.46) 0.70 (0.44–1.11) 0.24 0.95 (0.76–1.19) 0.82 (0.65–1.03) 0.17 1.10 (0.90–1.36) 0.97 (0.77–1.22) 0.54
Combined Factors10 0.61 0.73 0.70
  None 1.0 0.96 (0.71–1.44) 0.83 (0.61–1.12) 0.07 1.00 (0.86–1.18) 0.79 (0.67–0.94) 0.004 0.92 (0.78–1.07) 0.94 (0.81–1.12) 0.42
  1 risk factor 1.0 0.98 (0.71–1.35) 0.85 (0.65–1.11) 0.11 0.90 (0.78–0.83) 0.71 (0.62–0.83) <0.001 1.03 (0.90–1.18) 0.87 (0.76–1.01) 0.11
  2 risk factors 1.0 1.23 (0.77–1.95) 1.03 (0.69–1.54) 0.61 1.03 (0.84–1.27) 0.89 (0.72–1.09) 0.20 1.03 (0.85–1.25) 0.97 (0.79–1.18) 0.80
  3+ risk factors 1.0 0.39 (0.14–1.05) 0.39 (0.18–0.83) 0.04 0.91 (0.55–1.52) 1.03 (0.61–1.75) 0.88 1.20 (0.74–1.93) 1.15 (0.71–1.87) 0.54
1

Score evaluated as a continuous variable in Cox regression model.

2

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, menarche age, menopause age, parity and BMI/alcohol/physical activity in model where BMI/alcohol/physical activity score were not exposure of interest.

3

Tertiles.

4

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, menarche age, menopause age, parity and BMI/alcohol/physical activity in model where BMI/alcohol/physical activity score were not exposure of interest.

5

Age at menopause – age at menarche = years of potential fertility.

6

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, parity, menarche age, menopause age, parity and BMI/alcohol/physical activity in model where BMI/alcohol/physical activity score were not exposure of interest.

7

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, family history of breast cancer, menopause age, menarche age, menarche age, menopause age, parity and BMI/alcohol/physical activity in model where BMI/alcohol/physical activity score were not exposure of interest.

8

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy, menopause age, menarche age, parity, menarche age, menopause age, parity and BMI/alcohol/physical activity in model where BMI/alcohol/physical activity score were not exposure of interest.

9

Breast cancer; second degree = grandmother only, First degree = history in mother/sister.

10

Unadjusted and adjusted for age, smoking, education, hormone replacement therapy and menarche age, menopause age, parity and BMI/alcohol/physical activity in model where BMI/alcohol/physical activity score were not exposure of interest.

DISCUSSION

Our results suggest that better adherence to the WCFR/AICR cancer prevention guidelines is associated with a lower risk of postmenopausal breast cancer, regardless of a woman’s non-modifiable risk factors. However, the association was weaker among women who had more non-modifiable risk factors compared with those with fewer non-modifiable risk factors. Our study findings also confirmed the WCRF/AICR CUP report’s statement that adherence to the recommendations to limit alcohol intake and to maintain a healthy body weight may be the most important recommendations of the WCRF/AICR guidelines for prevention of postmenopausal breast cancer. Conversely, adherence to diet recommendations was unassociated with breast cancer incidence, while higher physical activity was non-significantly inversely associated in this population.

To our knowledge, no previous studies have evaluated whether relationships between dietary, body weight and physical activity recommendations and risk of postmenopausal breast cancer differ by the presence or absence of multiple non-modifiable risk factors. Dietary habits, especially alcohol consumption, body composition and physical activity are hypothesized to contribute to variability in hormone levels, which could contribute to cancer risk, especially in women who are already at risk for breast cancer due to non-modifiable factors.3033 Previous research indicates that women at high risk for breast cancer, due to a family history of breast cancer, are no more likely to adhere to cancer prevention recommendations.34, 35 Consistent with prior studies, when individual non-modifiable risk factors were evaluated, such as family history, benefits of adherence did not appear to differ by the presence/absence of a non-modifiable risk factor.3638 However, among women with multiple non-modifiable risk factors, higher adherence to cancer prevention recommendations was not associated with breast cancer risk. One possible explanation for the somewhat weaker association among women with multiple non-modifiable risk factors may be that the effects of the non-modifiable risk factor moderate the benefits of adherence. For example, a higher body weight has been shown to be associated with risk of postmenopausal hormone receptor positive (HR+) breast cancer.39, 40 Similarly, younger age at menarche, older age at menopause and being nulliparous are also more strongly associated with HR+ breast cancer.40, 41 In both examples, sex hormone levels are considered to have a role in development of HR+ breast cancer, and it may be that having several sex hormone-related risk factors counters the effects of maintaining a normal body weight.39, 41 However, it is also important to note that tests for interaction were non-significant, adherence was generally still associated with lower cancer incidence and is likely beneficial for overall health and prevention of other types of cancer among women who have non-modifiable risk factors.

Despite differences in analytic approaches in previous studies, adherence to cancer prevention guidelines has been consistently associated with a lower risk of breast cancer. Consistent with our results, five prior studies observed that adhering to cancer prevention guidelines was associated with lower incidence of breast cancer.911, 13, 16 A previous study in the IWHS found that adherence to the 1997 WCFR/AICR recommendations was associated with lower risk of all cancer, but a clear dose-response pattern to the association was not observed.8 Absolute risk difference for adherence to more recommendations compared to fewer recommendations was small, but it is important to note that these guidelines are intended to reduce the burden of cancer overall and some recommendations would not be expected to be associated with breast cancer risk based on previous research and biological mechanisms. In support of the goal of overall cancer reduction, the risk difference was larger in the previously published IWHS analysis that evaluated all cancers combined.8

This previous study did not evaluate specific cancer types, and the WCFR/AICR guidelines have evolved over time to incorporate more recent research. Two other previous analyses evaluated cancer survivors in the IWHS cohort and found that greater adherence to the 2007 WCRF/AICR guidelines was associated with lower all-cause mortality28 and higher mental and physical health-related quality of life.27, 28

No previous studies have evaluated combined diet adherence and breast cancer incidence; however, our results for the adherence to individual dietary recommendations and breast cancer risk are largely consistent with previous studies. Similar to our findings, all of three previously published studies evaluating adherence to individual recommendations in cancer prevention guidelines and breast cancer incidence reported that adherence to alcohol intake recommendations was associated with lower breast cancer incidence.9, 10, 13 Additionally, higher alcohol intake42, 43 is an established risk factor for postmenopausal breast cancer risk.18 Ethanol is an established carcinogen, which may disrupt folate metabolism and influence DNA repair and DNA methylation patterns.44 Additionally, ethanol is associated with elevated levels of sex hormones, which is linked with increased breast cancer risk.45, 46 Meanwhile, associations with other dietary factors, such as fruit and vegetable intake and red and processed meat intake have not been consistently associated with breast cancer risk.19, 43, 47 Reasons for differences in associations with adherence to other dietary factors may include differences in pre- and post-menopausal breast cancer etiology, possible heterogeneous associations by breast cancer subtypes, variances in analytic approaches, regional dietary differences (e.g., Iowa versus Washington), and temporal changes in dietary habits (e.g., IWHS baseline questionnaire 1986, VITAL baseline questionnaire 2000 – 2002).

Among the non-dietary recommendations, one prior study found adherence to the body weight recommendation to be associated with postmenopausal breast cancer incidence, which is in agreement with our results.9 The two studies that found no association evaluated pre- and postmenopausal breast cancer combined,10, 13 which may explain the differing results. Body fatness has been more strongly associated with increased postmenopausal risk while it may be inversely associated with premenopausal breast cancer risk.18 One proposed mechanism behind pre- and postmenopausal differences is contribution of adipose tissue to levels of circulating estrogens. Among postmenopausal women, adipose tissue becomes an important contributing source of estrogen and higher circulating estrogen levels have been positively associated with postmenopausal breast cancer risk.39 While higher levels of physical activity may be associated with lower risk for breast cancer;25, 48, 49 consistent with our findings, the three prior adherence studies9, 10, 13 and a previous report in the IWHS population did not find an association between physical activity and breast cancer risk.50

Some strengths of this study include the more than 23 years of follow-up and the large number of incident breast cancer cases, which allowed us to stratify the analyses to evaluate whether adherence to guidelines and breast cancer risk differed according to established risk factors for breast cancer. A majority of women in this study adhered to at least four and less than six recommendations. The relatively similar diet and other lifestyle exposures among these women may limit the ability to observe differences at extreme ends of the exposure spectrum in the interaction analyses, particularly in the risk score analysis, where numbers of women with multiple risk factors is smaller. The cut point for our height analysis was based on the height distribution within our cohort and among women in the general population of the United States, and may not reflect a true point at which risk of breast cancer truly differs between the two categories. However, results did not differ when different cut points were used or when data were evaluated as quartiles. It is also important to note that this is an observational study so residual confounding or unknown related factors may influence associations and direct effects of adherence cannot be ascertained.

Overall, our results indicate that better adherence to the 2007 WCRF/AICR cancer prevention guidelines may reduce postmenopausal breast cancer risk. This finding was apparent, regardless of the presence of non-modifiable risk factors. These results also suggest that maintaining normal body weight and limiting alcohol consumption may be particularly helpful recommendations for decreasing risk of postmenopausal breast cancer.

Supplementary Material

Supplementary Tables

Novelty and Impact.

Women with non-modifiable breast cancer risk factors may be especially motivated to make diet and physical activity changes to reduce their breast cancer risk. However, whether these women derive equal, or potentially greater, benefit from healthy behaviors compared to women without these non-modifiable breast cancer risk factors is unclear. This article contributes important data on the benefits of adherence to the WCRF/AICR cancer prevention guidelines among women at higher risk for breast cancer.

Acknowledgments

The Iowa Women’s Health Study is funded by National Cancer Institute R01 CA039742. At the time of the analysis, SJON was supported by National Cancer Institute T32 CA132670.

Footnotes

COMPETING INTERESTS

None of the authors have any competing interests.

References

  • 1.U.S. National Cancer Institute. SEER Stat Fact Sheets: Breast. 2012;2013 [Google Scholar]
  • 2.American Cancer Society. Breast Cancer: Causes, Risk Factors, and Prevention Topics. 2013;2013 [Google Scholar]
  • 3.Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011;12:785–94. doi: 10.1016/S1470-2045(11)70154-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev. 1993;15:110–32. doi: 10.1093/oxfordjournals.epirev.a036096. [DOI] [PubMed] [Google Scholar]
  • 5.van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514–27. doi: 10.1093/aje/152.6.514. [DOI] [PubMed] [Google Scholar]
  • 6.Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast cancer research : BCR. 2005;7:131–42. doi: 10.1186/bcr1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Poynter JN, Inoue-Choi M, Ross JA, Jacobs DR, Jr, Robien K. Reproductive, lifestyle, and anthropometric risk factors for cancer in elderly women. Cancer Epidemiol Biomarkers Prev. 2013;22:681–7. doi: 10.1158/1055-9965.EPI-12-0966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cerhan JR, Potter JD, Gilmore JM, Janney CA, Kushi LH, Lazovich D, Anderson KE, Sellers TA, Folsom AR. Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2004;13:1114–20. [PubMed] [Google Scholar]
  • 9.Hastert TA, Beresford SA, Patterson RE, Kristal AR, White E. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2013;22:1498–508. doi: 10.1158/1055-9965.EPI-13-0210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Catsburg C, Miller AB, Rohan TE. Adherence to cancer prevention guidelines and risk of breast cancer. Int J Cancer. 2014;135:2444–52. doi: 10.1002/ijc.28887. [DOI] [PubMed] [Google Scholar]
  • 11.Romaguera D, Vergnaud AC, Peeters PH, van Gils CH, Chan DS, Ferrari P, Romieu I, Jenab M, Slimani N, Clavel-Chapelon F, Fagherazzi G, Perquier F, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. 2012;96:150–63. doi: 10.3945/ajcn.111.031674. [DOI] [PubMed] [Google Scholar]
  • 12.Vergnaud AC, Romaguera D, Peeters PH, van Gils CH, Chan DS, Romieu I, Freisling H, Ferrari P, Clavel-Chapelon F, Fagherazzi G, Dartois L, Li K, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4. Am J Clin Nutr. 2013;97:1107–20. doi: 10.3945/ajcn.112.049569. [DOI] [PubMed] [Google Scholar]
  • 13.Makarem N, Lin Y, Bandera EV, Jacques PF, Parekh N. Concordance with World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991–2008) Cancer Causes Control. 2015;26:277–86. doi: 10.1007/s10552-014-0509-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ocke MC, Bueno-de-Mesquita HB, Feskens EJ, Kromhout D, Menotti A, Blackburn H. Adherence to the European Code Against Cancer in relation to long-term cancer mortality: intercohort comparisons from the Seven Countries Study. Nutr Cancer. 1998;30:14–20. doi: 10.1080/01635589809514634. [DOI] [PubMed] [Google Scholar]
  • 15.McCullough ML, Patel AV, Kushi LH, Patel R, Willett WC, Doyle C, Thun MJ, Gapstur SM. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev. 2011;20:1089–97. doi: 10.1158/1055-9965.EPI-10-1173. [DOI] [PubMed] [Google Scholar]
  • 16.Kabat GC, Matthews CE, Kamensky V, Hollenbeck AR, Rohan TE. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. Am J Clin Nutr. 2015;101:558–69. doi: 10.3945/ajcn.114.094854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Thomson CA, McCullough ML, Wertheim BC, Chlebowski RT, Martinez ME, Stefanick ML, Rohan TE, Manson JE, Tindle HA, Ockene J, Vitolins MZ, Wactawski-Wende J, et al. Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative. Cancer prevention research. 2014;7:42–53. doi: 10.1158/1940-6207.CAPR-13-0258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Research WCRFAAfC. Contiuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer. 2010 [Google Scholar]
  • 19.World Cancer Research Fund/American Institute for Cancer. Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. Washington, D.C: American Institute for Cancer; 2007. [Google Scholar]
  • 20.Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res. 1989;49:6828–31. [PubMed] [Google Scholar]
  • 21.Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer. 1995;76:275–83. doi: 10.1002/1097-0142(19950715)76:2<275::aid-cncr2820760218>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  • 22.Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML. Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc. 1987;87:43–7. [PubMed] [Google Scholar]
  • 23.Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65. doi: 10.1093/oxfordjournals.aje.a114086. [DOI] [PubMed] [Google Scholar]
  • 24.Munger RG, Folsom AR, Kushi LH, Kaye SA, Sellers TA. Dietary assessment of older Iowa women with a food frequency questionnaire: nutrient intake, reproducibility, and comparison with 24-hour dietary recall interviews. Am J Epidemiol. 1992;136:192–200. doi: 10.1093/oxfordjournals.aje.a116485. [DOI] [PubMed] [Google Scholar]
  • 25.Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med. 2006;166:2478–83. doi: 10.1001/archinte.166.22.2478. [DOI] [PubMed] [Google Scholar]
  • 26.U.S. Department of Agriculture and U.S. Department of Health and Human Services. 7. Washington, DC: U.S. Goverment Printing Office; 2010. Dietary Guidelines for Americans 2010. [Google Scholar]
  • 27.Inoue-Choi M, Lazovich D, Prizment AE, Robien K. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention is associated with better health-related quality of life among elderly female cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31:1758–66. doi: 10.1200/JCO.2012.45.4462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Inoue-Choi M, Robien K, Lazovich D. Adherence to the WCRF/AICR guidelines for cancer prevention is associated with lower mortality among older female cancer survivors. Cancer Epidemiol Biomarkers Prev. 2013;22:792–802. doi: 10.1158/1055-9965.EPI-13-0054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162:199–200. doi: 10.1093/aje/kwi188. [DOI] [PubMed] [Google Scholar]
  • 30.Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology. 2009;150:2537–42. doi: 10.1210/en.2009-0070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Winzer BM, Whiteman DC, Reeves MM, Paratz JD. Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control. 2011;22:811–26. doi: 10.1007/s10552-011-9761-4. [DOI] [PubMed] [Google Scholar]
  • 32.Purohit V. Moderate alcohol consumption and estrogen levels in postmenopausal women: a review. Alcohol Clin Exp Res. 1998;22:994–7. doi: 10.1111/j.1530-0277.1998.tb03694.x. [DOI] [PubMed] [Google Scholar]
  • 33.Carruba G, Granata OM, Pala V, Campisi I, Agostara B, Cusimano R, Ravazzolo B, Traina A. A traditional Mediterranean diet decreases endogenous estrogens in healthy postmenopausal women. Nutr Cancer. 2006;56:253–9. doi: 10.1207/s15327914nc5602_18. [DOI] [PubMed] [Google Scholar]
  • 34.Bostean G, Crespi CM, McCarthy WJ. Associations among family history of cancer, cancer screening and lifestyle behaviors: a population-based study. Cancer Causes Control. 2013;24:1491–503. doi: 10.1007/s10552-013-0226-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Spector D, Deroo LA, Sandler DP. Lifestyle behaviors in black and white women with a family history of breast cancer. Prev Med. 2011;52:394–7. doi: 10.1016/j.ypmed.2011.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer. 2003;106:96–102. doi: 10.1002/ijc.11186. [DOI] [PubMed] [Google Scholar]
  • 37.Cloud AJ, Thai A, Liao Y, Terry MB. The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry. Breast Cancer Res Treat. 2015;149:537–46. doi: 10.1007/s10549-014-3234-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Petracci E, Decarli A, Schairer C, Pfeiffer RM, Pee D, Masala G, Palli D, Gail MH. Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst. 2011;103:1037–48. doi: 10.1093/jnci/djr172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Byers T, Sedjo RL. Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms. Endocrine-related cancer. 2015;22:R125–R34. doi: 10.1530/ERC-14-0580. [DOI] [PubMed] [Google Scholar]
  • 40.Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol. 2009;169:1251–9. doi: 10.1093/aje/kwp036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast cancer research : BCR. 2006;8:R43. doi: 10.1186/bcr1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306:1884–90. doi: 10.1001/jama.2011.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101:384–98. doi: 10.1093/jnci/djp018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Scoccianti C, Cecchini M, Anderson AS, Berrino F, Boutron-Ruault MC, Espina C, Key TJ, Leitzmann M, Norat T, Powers H, Wiseman M, Romieu I. European Code against Cancer 4th Edition: Alcohol drinking and cancer. Cancer epidemiology. 2015 doi: 10.1016/j.canep.2015.01.007. [DOI] [PubMed] [Google Scholar]
  • 45.Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer. 2011;105:709–22. doi: 10.1038/bjc.2011.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008;630:148–65. [PubMed] [Google Scholar]
  • 47.Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: a review of the prospective observational studies. Cancer. 2007;109:2712–49. doi: 10.1002/cncr.22654. [DOI] [PubMed] [Google Scholar]
  • 48.Lahmann PH, Friedenreich C, Schuit AJ, Salvini S, Allen NE, Key TJ, Khaw KT, Bingham S, Peeters PH, Monninkhof E, Bueno-de-Mesquita HB, Wirfalt E, et al. Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2007;16:36–42. doi: 10.1158/1055-9965.EPI-06-0582. [DOI] [PubMed] [Google Scholar]
  • 49.Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, van Leeuwen FE. Physical activity and breast cancer: a systematic review. Epidemiology. 2007;18:137–57. doi: 10.1097/01.ede.0000251167.75581.98. [DOI] [PubMed] [Google Scholar]
  • 50.Moore DB, Folsom AR, Mink PJ, Hong CP, Anderson KE, Kushi LH. Physical activity and incidence of postmenopausal breast cancer. Epidemiology. 2000;11:292–6. doi: 10.1097/00001648-200005000-00011. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Tables

RESOURCES